Literature DB >> 9029409

Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum. Short communication.

J Opacka-Juffry1, S Ashworth, A M Sullivan, R B Banati, S B Blunt.   

Abstract

The lesion caused by a single 6-hydroxydopamine injection into rat striatum was evaluated. In vivo positron emission tomography using a dopamine reuptake tracer revealed no consistent reduction in striatal dopamine transporter. Amphetamine rotation test was negative up to 18 weeks. A 21% reduction in striatal dopamine seen at 11 weeks was not detectable at 18 weeks. Tyrosine hydroxylase-positive neurone counts showed no decline in substantia nigra. Our results suggest that this lesion may be subject to compensation and therefore should be used with caution in studies on neuroprotective treatments of Parkinson' disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9029409     DOI: 10.1007/BF01271256

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  11 in total

1.  Dissociation between circling behaviour and striatal dopamine activity following unilateral deltamethrin administration to rats.

Authors:  M E Brodie; J Opacka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

2.  Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra.

Authors:  V Blanchard; P Anglade; G Dziewczapolski; M Savasta; Y Agid; R Raisman-Vozari
Journal:  Brain Res       Date:  1996-02-19       Impact factor: 3.252

3.  The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography.

Authors:  S B Blunt; P Jenner; C D Marsden
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

4.  The design and physical characteristics of a small animal positron emission tomograph.

Authors:  P M Bloomfield; S Rajeswaran; T J Spinks; S P Hume; R Myers; S Ashworth; K M Clifford; W F Jones; L G Byars; J Young
Journal:  Phys Med Biol       Date:  1995-06       Impact factor: 3.609

5.  Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA.

Authors:  F Hefti; E Melamed; B J Sahakian; R J Wurtman
Journal:  Pharmacol Biochem Behav       Date:  1980-02       Impact factor: 3.533

6.  GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET.

Authors:  J Opacka-Juffry; S Ashworth; S P Hume; D Martin; D J Brooks; S B Blunt
Journal:  Neuroreport       Date:  1995-12-29       Impact factor: 1.837

7.  Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter.

Authors:  S P Hume; S K Luthra; D J Brown; J Opacka-Juffry; S Osman; S Ashworth; R Myers; F Brady; F I Carroll; M J Kuhar; D J Brooks
Journal:  Nucl Med Biol       Date:  1996-04       Impact factor: 2.408

8.  Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.

Authors:  T E Robinson; I Q Whishaw
Journal:  Brain Res       Date:  1988-05-31       Impact factor: 3.252

9.  Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

Authors:  H Sauer; W H Oertel
Journal:  Neuroscience       Date:  1994-03       Impact factor: 3.590

10.  Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.

Authors:  S Przedborski; M Levivier; H Jiang; M Ferreira; V Jackson-Lewis; D Donaldson; D M Togasaki
Journal:  Neuroscience       Date:  1995-08       Impact factor: 3.590

View more
  2 in total

1.  1-Methyl-4-phenylpyridinium stereotactic infusion completely and specifically ablated the nigrostriatal dopaminergic pathway in rhesus macaque.

Authors:  Xiaoguang Lei; Hao Li; Baihui Huang; Joshua Rizak; Ling Li; Liqi Xu; Tianzhuang Huang; Li Liu; Jing Wu; Longbao Lü; Zhengbo Wang; Yingzhou Hu; Weidong Le; Xingli Deng; Jiali Li; Yonggang Yao; Lin Xu; Xintian Hu; Baorong Zhang
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

Review 2.  Role of Nuclear Imaging to Understand the Neural Substrates of Brain Disorders in Laboratory Animals: Current Status and Future Prospects.

Authors:  Annunziata D'Elia; Sara Schiavi; Andrea Soluri; Roberto Massari; Alessandro Soluri; Viviana Trezza
Journal:  Front Behav Neurosci       Date:  2020-12-11       Impact factor: 3.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.